SCHEMBL19081872

SCHEMBL19081872

c1ccc(-c2ccc3cc(-c4c5ccccc5c(-c5ccc6sc7cc8oc9ccccc9c8cc7c6c5)c5ccccc45)ccc3c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.37
PLA2G4A P47712 4/20 0.37
AHR P35869 2/20 0.35
PGR P06401 1/20 0.35
CASP3 P42574 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
HCRTR1 O43613 1/20 0.34
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
PLA2G10 O15496 1/20 0.33
MAOA P21397 1/20 0.33
LIMK1 P53667 1/20 0.33
F9 P00740 2/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19110011 0.91 AHR (0.34) PLA2G2APLA2G4AAHRPGRCASP3
SCHEMBL19076655 0.91 AHR (0.35) PLA2G2APLA2G4AAHRPGRCASP3
SCHEMBL19076771 0.91 AHR (0.35) PLA2G2APLA2G4AAHRPGRCASP3
SCHEMBL19081869 0.88 PGR (0.35) PLA2G2APLA2G4AAHRPGRESR1
SCHEMBL18268514 0.88 AHR (0.37) AHRCASP3SENP7SENP6HCRTR1
SCHEMBL24342845 0.87 AHR (0.33) PLA2G2APLA2G4AAHRCASP3SENP7
SCHEMBL19076726 0.87 AHR (0.35) PLA2G2APLA2G4AAHRCASP3SENP7
SCHEMBL17945388 0.87 CASP3 (0.33) PLA2G2APLA2G4APGRCASP3SENP7
SCHEMBL18268532 0.87 CASP3 (0.33) PLA2G2APLA2G4APGRCASP3SENP7
SCHEMBL19076852 0.87 AHR (0.36) AHRCASP3SENP7SENP6HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 PLA2G2A 4330/4885PLA2G4A 4338/4885AHR 2453/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 PLA2G2A 4330/4885PLA2G4A 4338/4885AHR 2453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.